Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, today announced that it has received FDA 510(k) clearance to commercialize FasTouchTM
Mr. Blumenreich, an investment banker at Raymond James, brings nearly 20 years of experience advising growth-oriented medical device companies and has completed numerous capital raising and M&A transactions in the aesthetics, cardiovascular, diabetes, diagnostics, general surgery, orthopedics, and spine subsectors.
AMIRIM, Israel, May 9, 2012 /PRNewswire/ —
Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, announced today that it has appointed Karl A. LeBlanc, MD, MBA, FACS and David B. Earle MD, FACS as Medical Advisors.
Schedule a demo
Click below to schedule a demo or have a sales rep contact you